La Merie Publishing

Set up in 2002, La Merie Publishing is an authoritative supplier of the cutting-edge information on the biopharmaceutical industry, with a special focus on the research and development pipeline and covering issues related to biologics, including peptides, antibodies, DNA, RNA, proteins and cell therapy.

The company’s service portfolio is represented by various formats and price levels, and includes Brief Reports, Full Reports and Competitor Analysis Reports. Competitor Analysis Reports present no frills, but accurate data on the pipeline of research and development projects for diseases, targets, companies and technologies. The data are fully referenced and delivered in a tabular format. Brief Reports covering Target Pipelines contain all-round assessments of both business and scientific perspectives of new targets. Full Reports present deep analyses of product portfolios, competitive landscape, R&D pipelines and discussions of the pipeline perspectives.

Research Reports By La Merie Publishing

Found 215 publications
Report Package: Bispecific Antibodies US$ 3,550.00 US$ 2,840.00 Jul, 2019
Competitor Analysis: WT1-Targeted Immunotherapy US$ 354.00 Jun, 2018 52 pages
Competitor Analysis: Kallikrein Inhibitors 2017 US$ 170.00 Apr, 2017 17 pages
Competitor Analysis Immunotoxins 2016 US$ 225.00 Sep, 2016 31 pages
1 2 3 4 5
Skip to top

Analytics & News by La Merie Publishing